Pancreatoduodenectomy in the management of chronic pancreatitis.
The records of 73 consecutive patients who underwent pancreatoduodenectomy for chronic pancreatitis between 1960 and 1985 were reviewed. The median size of the pancreatic duct was 5 mm. Two operative deaths (2.7%) occurred early in the series. Eighty-eight percent, 86%, and 79% of the patients had improvement in pain at six months, two years, and five years, respectively. Diabetes was present preoperatively in 25% of patients and postoperatively in 37%, 45%, and 69% of patients at six months, two years, and five years, respectively. Pancreatic enzyme preparations were used preoperatively by 26% of patients; this use increased to 75% by five years. Only four of 17 late deaths could be related to diabetes or malnutrition. In most patients, pancreatoduodenectomy achieves long-term pain improvement and permits return to normal activities. Selection of patients is important to decrease the late morbidity and mortality.
D000328:Adult; D000368:Aged; D002114:Calcinosis / Q000601:surgery; D003920:Diabetes Mellitus / Q000209:etiology; D004386:Duodenum / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D010180:Pancreatectomy / Q000009:adverse effects / Q000379:methods*; D010183:Pancreatic Ducts / Q000601:surgery; D010192:Pancreatic Pseudocyst / Q000601:surgery; D010195:Pancreatitis / Q000000981:diagnostic imaging / Q000601:surgery*; D011788:Quality of Life; D011859:Radiography; D012086:Reoperation
D009294:Narcotics